Rayvow is a medicine used to treat migraine with or without aura (unusual visual or other sensory experiences) in adults. Rayvow contains the active substance lasmiditan.
Therapeutic Indication
### Therapeutic indication RAYVOW is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.
Therapeutic Area (MeSH)
ATC Code
N02CC08
ATC Item
lasmiditan
Pharmacotherapeutic Group
Analgesics
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| lasmiditan succinate | N/A | Lasmiditan Succinate |
EMA Name
Rayvow
Medicine Name
Rayvow
Aliases
N/ANo risk management plan link.
